Diabetic retinopathy: Looking forward to 2030

TE Tan, TY Wong - Frontiers in Endocrinology, 2023‏ - frontiersin.org
Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a
problem with significant global health impact. Major advances in diagnostics, technology …

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023‏ - diabetesjournals.org
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Molecular mechanism of VEGF and its role in pathological angiogenesis

A Ahmad, MI Nawaz - Journal of cellular biochemistry, 2022‏ - Wiley Online Library
Over the last seven decades, a significant scientific contribution took place in the delineation
of the implications of vascular endothelial‐derived growth factor (VEGF) in the processes of …

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2024

Diabetes Care, 2024‏ - diabetesjournals.org
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

KY Lin, WH Hsih, YB Lin, CY Wen… - Journal of diabetes …, 2021‏ - Wiley Online Library
Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus and
is the leading cause of visual loss in the elderly. Hyperglycemia and altered metabolic …

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021

American Diabetes Association - Diabetes Care, 2021‏ - diabetesjournals.org
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …

Diabetic retinopathy: pathophysiology and treatments

W Wang, ACY Lo - International journal of molecular sciences, 2018‏ - mdpi.com
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has
long been recognized as a microvascular disease. The diagnosis of DR relies on the …

VEGF in signaling and disease: beyond discovery and development

RS Apte, DS Chen, N Ferrara - Cell, 2019‏ - cell.com
The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our
understanding of vasculogenesis and angiogenesis during development and physiological …

Diabetic retinopathy preferred practice pattern®

CJ Flaxel, RA Adelman, ST Bailey, A Fawzi, JI Lim… - …, 2020‏ - aaojournal.org
Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy

A Arrigo, E Aragona, F Bandello - Annals of medicine, 2022‏ - Taylor & Francis
Diabetic retinopathy (DR) is the most common microangiopathic complication of diabetes
mellitus, representing a major cause of visual impairment in developed countries …